Hisayuki Yokoyama
Overview
Explore the profile of Hisayuki Yokoyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mina R, Mylin A, Yokoyama H, Magen H, Alsdorf W, Minnema M, et al.
Lancet Haematol
. 2025 Jan;
12(1):e45-e56.
PMID: 39756844
Background: In CARTITUDE-4, ciltacabtagene autoleucel (cilta-cel) significantly improved progression-free survival (primary endpoint; previously reported) versus standard of care in patients with relapsed, lenalidomide-refractory multiple myeloma. We report here patient-reported outcomes....
2.
Ichikawa S, Abe H, Morota N, Kawajiri A, Nakagawa R, Inokura K, et al.
Intern Med
. 2024 Nov;
PMID: 39566977
Nodal Epstein-Barr virus-positive T/NK-cell lymphoma (EB-nTNKL) is an extremely rare disease characterized by an aggressive clinical course and poor prognosis, for which treatment strategies have not yet been established. We...
3.
Ichikawa S, Abe H, Komatsu H, Takenaka K, Nakamura H, Morota N, et al.
Intern Med
. 2024 Sep;
PMID: 39343568
A 21-year-old man was diagnosed with myeloid/natural killer precursor leukemia (MNKPL) with bone marrow infiltration of blasts of cyCD3, CD7, CD33, CD34, CD56, HLA-DR, cyMPO, and TdT immunophenotypes. Although hyper-CVAD...
4.
Sato A, Yusa N, Takamori H, Shimizu E, Yokoyama K, Ichikawa S, et al.
J Pathol
. 2024 Sep;
264(3):243-249.
PMID: 39225049
Histiocytic neoplasms (HNs) in adults have been reported to be associated with a high prevalence of coexisting haematological and solid malignancies. While a proportion of coexisting HNs and haematological malignancies...
5.
Otsuki A, Kumondai M, Kobayashi D, Kikuchi M, Ueki Y, Sato Y, et al.
Yakugaku Zasshi
. 2024 Jun;
144(7):775-779.
PMID: 38945852
Venetoclax (VEN) is used in patients with acute myeloid leukemia (AML) and is primarily metabolized by CYP3A4, a major drug-metabolizing enzyme. Patients with AML simultaneously administered VEN and CYP3A4 inhibitors...
6.
Iida S, Ito S, Yokoyama H, Ishida T, Nagai Y, Handa H, et al.
Jpn J Clin Oncol
. 2024 May;
54(9):991-1000.
PMID: 38794892
Background: Despite advances, most patients with multiple myeloma (MM) experience relapse and repeat multiple treatment lines, highlighting an unmet need for patients with relapsed or refractory MM (RRMM). Bispecific antibodies...
7.
Sakurai K, Saito K, Hatta S, Katsuoka Y, Meguro K, Yokoyama H, et al.
Clin Case Rep
. 2024 Apr;
12(5):e8832.
PMID: 38681032
Haploidentical hematopoietic stem cell transplantation (HSCT) with posttransplant cyclophosphamide is an alternative treatment for aplastic anemia-paroxysmal nocturnal hemoglobinuria (PNH) syndrome with poor prognostic factors. Ravulizumab treatment for PNH before HSCT...
8.
Sasaki Y, Ichikawa S, Sakurai K, Nakamura H, Inokura K, Onodera K, et al.
Rinsho Ketsueki
. 2024 Apr;
65(3):147-152.
PMID: 38569857
A 41-year-old woman with right shoulder pain was found to have multiple tumors with osteolysis and M-proteinemia. Abnormal plasma cells (CD38+, CD138+, Igλ≫κ) were detected in 1.4% of bone marrow...
9.
Ichikawa S, Yokoyama H, Fukuhara N, Ichinohasama R, Harigae H
Int J Hematol
. 2024 Jan;
119(3):215-216.
PMID: 38289575
No abstract available.
10.
Usuki K, Ohtake S, Honda S, Matsuda M, Wakita A, Nawa Y, et al.
Int J Hematol
. 2023 Dec;
119(2):130-145.
PMID: 38091231
We conducted a multicenter, prospective observational study of acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia (CMML) in Japan. From August 2011 to January 2016, we enrolled...